Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS); Amended Notice of Meeting, 51032-51033 [2020-18160]

Download as PDF 51032 Federal Register / Vol. 85, No. 161 / Wednesday, August 19, 2020 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. NIOSH 339] Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting and request for comment. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC, announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH). This meeting is open to the public, limited only by the ports available. The audio conference line has 150 ports for callers. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference (information below). SUMMARY: The meeting will be held on October 27, 2020 from 11:00 a.m. to 1:00 p.m., EDT. Written comments must be received on or before October 20, 2020. Docket number NIOSH–339, will close on October 20, 2020. ADDRESSES: You may submit comments, identified by Docket No. NIOSH–339 by the following method listed below. CDC does not accept comment by email. • Mail: Docket number NIOSH–339 c/ o Sherri Diana, NIOSH Docket Office, National Institute for Occupational Safety and Health, 1090 Tusculum Avenue, MS C–34, Cincinnati, Ohio 45226. Instructions: All submissions received must include the Agency name and Docket Number. All relevant comments received will be posted without change to https://www.cdc.gov/niosh/docket/ default.html, including any personal information provided. For access to the docket to read background documents or comments received, go to https:// www.cdc.gov/niosh/docket/ default.html. jbell on DSKJLSW7X2PROD with NOTICES DATES: FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C–24, Cincinnati, Ohio 45226, Telephone VerDate Sep<11>2014 16:34 Aug 18, 2020 Jkt 250001 (513) 533–6800, Toll Free 1(800)CDC– INFO, Email ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The Advisory Board’s charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on March 22, 2020, and will terminate on March 22, 2022. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters To Be Considered: The agenda will include discussions on: Work Group and Subcommittee Reports; Update on the Status of SEC Petitions; Plans for the December 2020 Advisory Board Meeting; and Advisory Board Correspondence. Agenda items are subject to change as priorities dictate. Meeting Information: Audio Conference Call via FTS Conferencing. The USA toll-free dial-in number is 1– 866–659–0537; the pass code is 9933701. PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 Public Participation Comments received are part of the public record and are subject to public disclosure. Do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/ near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket. CDC does not accept comment by email. Written Public Comment: Written comments will also be accepted from those unable to attend the public session per the instructions provided in the address section above. Written comments received in advance of the meeting will be included in the official record of the meeting. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–18162 Filed 8–18–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS); Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS); September 17, 2020, from 9:30 a.m. to 3:00 p.m., EDT, and September 18, 2020, from 9:00 a.m. to 11:30 a.m., EDT, in the original FRN. The teleconference access is E:\FR\FM\19AUN1.SGM 19AUN1 Federal Register / Vol. 85, No. 161 / Wednesday, August 19, 2020 / Notices https://www.cdc.gov/nchs/about/bsc/ bsc_meetings.htm which was published in the Federal Register on July 31, 2020, Volume 85, Number 148, page 46121. The meeting is being amended to change the meeting time and should read as follows: DATES: The meeting will be held on September 17, 2020, from 11:00 a.m. to 4:30 p.m., EDT and September 18, 2020, from 11:00 a.m. to 2:15 p.m., EDT. The meeting is open to the public. FOR FURTHER INFORMATION CONTACT: Sayeedha Uddin, M.D., M.P.H., Executive Secretary, NCHS/CDC, Board of Scientific Counselors, 3311 Toledo Road, Room 2627, Hyattsville, Maryland 20782, telephone (301) 458–4303, email SUddin@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–18160 Filed 8–18–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Lead Exposure and Prevention Advisory Committee (LEPAC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Lead Exposure and Prevention Advisory Committee (LEPAC). This meeting is open to the public by teleconference but advance registration by October 16, 2020 is needed to receive the information to join the meeting. The registration link is https:// rossstrategic.zoom.us/webinar/register/ WN_QsgX-UlJS02mWW8Kn8SUmg. The public comment period is scheduled on October 30, 2020 from 1:30 p.m. until 1:45 p.m. Individuals wishing to make a comment during the public comment period, please email your name, jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:34 Aug 18, 2020 Jkt 250001 organization, and phone number by October 16, 2020 to LEPAC@cdc.gov. DATES: The meeting will be held on October 30, 2020, from 9:00 a.m. to 4:30 p.m., EDT. ADDRESSES: Register in advance at https://rossstrategic.zoom.us/webinar/ register/WN_QsgXUlJS02mWW8Kn8SUmg to receive information to join the meeting. FOR FURTHER INFORMATION CONTACT: Ms. Perri Ruckart, M.P.H., Designated Federal Officer, National Center for Environmental Health, CDC, 4770 Buford Highway, Atlanta, GA 30341, Telephone: 770–488–3300; email address pruckart@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Lead Exposure and Prevention Advisory Committee was established under Section 2203 of Public Law 114–322, the Water Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j–27, Registry for Lead Exposure and Advisory Committee. The Secretary, Department of Health and Human Services (HHS) and by delegation, the Director, CDC and Administrator, NCEH/ATSDR, are authorized under Section 2203 of Public Law 114–322 (42 U.S.C. 300j–27) to review research and Federal programs and services related to lead poisoning and to identify effective services and best practices for addressing and preventing lead exposure in communities. The LEPAC is charged with providing advice and guidance to the Secretary, HHS, and the Director, CDC and Administrator, ATSDR, on the: (1) Review of Federal programs and services available to individual communities exposed to lead; (2) review current research on lead exposure to identify additional research needs; (3) review and identify best practices, or the need for best practices regarding lead screening and the prevention of lead poisoning; (4) identify effective services, including services relating to healthcare, education, and nutrition for individuals and communities affected by lead exposure and lead poisoning, including in consultation with, as appropriate, the lead exposure registry as established in Section 2203(b) of Public Law 114–322; and (5) undertake any other review or activities that the Secretary determines to be appropriate. Matters To Be Considered: The agenda will include discussions on the 2018 Federal Lead Action Plan; COVID–19 and CDC lead surveillance, lead laboratory methods; U.S. Housing and Urban Development’s (HUD) role in lead poisoning prevention; an update from CDC’s blood lead reference value PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 51033 workgroup; and a discussion on effective services and best practices regarding lead screening and lead poisoning prevention and research gaps. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–18161 Filed 8–18–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Community Living [OMB No. 0985–0004] Agency Information Collection Activities; Proposed Collection; Comment Request; Title III Supplemental Form to Financial Status Report (SF–425) Administration for Community Living, HHS. ACTION: Notice. AGENCY: The Administration for Community Living (ACL) is announcing an opportunity for the public to comment on the proposed collection of information listed above. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish a notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the Proposed Extension without Change and solicits comments on the information collection requirements related to Title III Supplemental Form to Financial Status Report (SF–425). DATES: Comments on the collection of information must be submitted electronically by 11:59 p.m. (EST) or postmarked by October 19, 2020. ADDRESSES: Submit electronic comments on the collection of information to: Alice Kelsey. Submit written comments on the collection of information to Administration for SUMMARY: E:\FR\FM\19AUN1.SGM 19AUN1

Agencies

[Federal Register Volume 85, Number 161 (Wednesday, August 19, 2020)]
[Notices]
[Pages 51032-51033]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18160]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Health 
Statistics (BSC, NCHS); Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Board of 
Scientific Counselors, National Center for Health Statistics (BSC, 
NCHS); September 17, 2020, from 9:30 a.m. to 3:00 p.m., EDT, and 
September 18, 2020, from 9:00 a.m. to 11:30 a.m., EDT, in the original 
FRN. The teleconference access is

[[Page 51033]]

https://www.cdc.gov/nchs/about/bsc/bsc_meetings.htm which was published 
in the Federal Register on July 31, 2020, Volume 85, Number 148, page 
46121.
    The meeting is being amended to change the meeting time and should 
read as follows:

DATES: The meeting will be held on September 17, 2020, from 11:00 a.m. 
to 4:30 p.m., EDT and September 18, 2020, from 11:00 a.m. to 2:15 p.m., 
EDT.
    The meeting is open to the public.

FOR FURTHER INFORMATION CONTACT: Sayeedha Uddin, M.D., M.P.H., 
Executive Secretary, NCHS/CDC, Board of Scientific Counselors, 3311 
Toledo Road, Room 2627, Hyattsville, Maryland 20782, telephone (301) 
458-4303, email [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-18160 Filed 8-18-20; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.